Commonwealth Equity Services
IMNM icon

Commonwealth Equity Services’s Immunome IMNM Stock Holding History

Commonwealth Equity Services’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,118
Closed -$236K – 4370
2025
Q3 		$236K Sell
20,118
-799
-4% -$7.95K ﹤0.01% 3828
2025
Q2 		$195K Buy
20,917
+372
+2% +$3.05K ﹤0.01% 3929
2025
Q1 		$138K Buy
20,545
+1,528
+8% +$14.7K ﹤0.01% 3932
2024
Q4 		$202K Buy
+19,017
New +$230K ﹤0.01% 3751

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Commonwealth Equity Services's IMNM Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Immunome (IMNM) in Q4 2025, closing a stake of 20,118 shares — an estimated $236K sold.

Commonwealth Equity Services first reported a position in IMNM in Q4 2024 and held it in 4 quarters. The position peaked at $236K in Q3 2025. 182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

  • Commonwealth Equity Services reported no remaining Immunome position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 20,118 Immunome shares in Q4 2025, an estimated $236K.
  • Commonwealth Equity Services first reported a position in Immunome in Q4 2024 and held it in 4 quarters.
  • Commonwealth Equity Services's Immunome position peaked at $236K in Q3 2025.
  • 182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.